Cyto-histology in NET: what is necessary today and what is the future?

Guido Rindi, Frediano Inzani, Gianluigi Petrone, Guido Fadda

Risultato della ricerca: Contributo in rivistaArticolo in rivista

12 Citazioni (Scopus)

Abstract

The carcinoid as originally described is part of the relatively large family of neuroendocrine neoplasia found in almost every organ. Historical reasons back their current definitions. Neuroendocrine cancer is most frequently observed in the lung and the digestive tract. In the lung is defined as carcinoid (typical and atypical) for well differentiated, low to intermediate grade, and small cell and large cell neuroendocrine carcinoma for poorly differentiated, high grade. In the digestive system are respectively defined as neuroendocrine tumor (NET) and neuroendocrine carcinoma (NEC) of small and large cell types. Grading and staging are developed for their clinical classification by the World Health Organization (WHO) and the American Joint Committee on Cancer (AJCC). In both anatomical sites the morphological features are overlapping, with bland histology for carcinoid and NET, and aggressive features with extensive necrosis, severe atypia and abundant, atypical mitoses for high grade cancer types. Such features are also essential diagnostic clues in cytological preparations. The confirmation of the neuroendocrine signature by immunohistochemistry is mandatory for the diagnosis; a minimum panel comprising chromogranin A and synaptophysin is recommended in the digestive system. In addition, the application of grading requires the mitotic count and or spotty necrosis assessment for lung, or the mitotic count and the Ki67 assessment in the digestive system.
Lingua originaleEnglish
pagine (da-a)381-391
Numero di pagine11
RivistaREVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume18
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Classification
  • Cytology
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Grading
  • Histology
  • Personalized medicine
  • Staging
  • Tailored therapy

Fingerprint

Entra nei temi di ricerca di 'Cyto-histology in NET: what is necessary today and what is the future?'. Insieme formano una fingerprint unica.

Cita questo